Raybow PharmaScience Attends CPhI Worldwide in Fiera Milano, Milan, Italy

Raybow PharmaScience Attends CPhI Worldwide in Fiera Milano, Milan, Italy Image

Milan, Italy - November 9, 2021

Raybow PharmaScience is attending this three day trade show and conference which gets underway today. This annual event typically attracts thousands of pharma suppliers and buyers across the full supply chain. Raybow last presented in-person at CPhI Worldwide in Frankfurt, Germany in 2019.

This is the one of the first major in-person European shows that Raybow has attended since Covid-19 shut down events and venues across Europe in the spring of 2020. Key executives attending the event include Peter Halkjaer-Knudsen, Executive Vice President, Dr. Dirk Hütten, Senior Director Business Development and Ryan Gil, Senior Manager, Business Development.

"We are excited to be able to meet our partners and customers in-person" said Halkjaer-Knudsen. "While we have all learned to use zoom, video and other technologies to keep on track, there is no substitute to meeting face-to-face."

Raybow PharmaScience booth at CPhI Worldwide, Milan, Italy

Raybow has taken a cautious approach to getting back to travel in an effort to keep employees safe and as a company this is a significant step to a return to more in-person events.

The in-person event runs for 3 days, ending on the 11th. There is also the opportunity for people unable to attend in Italy to set up online meetings following the event. Raybow will attend CPhI China in December in Shanghai and has plans to attend Chemoutsourcing in the U.S. in February, 2022. This will be our first in-person U.S. show since late 2019 although we have attended several virtual shows.

Raybow PharmaScience is a global Contract Drug and Manufacturing Organization (CDMO) with operations in China, Europe and the U.S. Raybow is focused on providing world class research and development capabilities in the pharmaceutical manufacturing space. Raybow has shown its commitment to the R&D side of the business launching two 10,000 square meter R&D centers in the past 3 years alone and hiring more than 600 new chemists in that same time frame. The company will open a 3rd 10,000 square meter R&D center in 2022.

Other Raybow News & Papers

Raybow PharmaScience Attends CPhI Worldwide in Fiera Milano, Milan, Italy

Raybow is attending CPhI Worldwide in Milan, Italy.

Raybow Pharmaceutical Announces Rebranding, Changes Name to Raybow PharmaScience

Raybow has unveiled changes to its’ name, with modifications to the iconic Rainbow Logo as part of a rebranding initiative designed to better reflect the company’s commitment to science.

Raybow PharmaScience announces $15.8 million expansion of U.S. site, tripling capacity and U.S. workforce

Raybow PharmaScience announces $15.8 million expansion of U.S. site, tripling capacity and U.S. workforce

Raybow Attends Bio-Europe Digital - Oct. 26th thru 29th, 2020

BIO-Europe® Digital 2020, the largest life science partnering event in Europe, runs October 26th-29th. This event is being held digitally and Raybow is there!

Green Chemistry in the development and manufacturing of pharmaceuticals

First of all, Green Chemistry is “the development of chemical products and processes to reduce or eliminate the use and generation of hazardous substances” and “is intended to apply to the development and full lifecycle of a chemical product” i.e. development, manufacturing, application and disposal.